奥卡西平
丙戊酸
中止
医学
药理学
肝酶
分裂情感障碍
麻醉
胃肠病学
内科学
卡马西平
癫痫
精神科
精神病
作者
Alanna Chait Mermelstein,Joseph Mermelstein,Tarek Adam,Benjamin D. Brody,Marc J. Dubin
摘要
Objective The aim of the present case report is to describe a potential interaction between valproic acid and oxcarbazepine that resulted in hepatic injury. Methods We report the case of a 46‐year‐old man with schizoaffective disorder who was cross‐titrated from valproic acid to oxcarbazepine because of liver injury. Results Initiation of oxcarbazepine four days after stopping valproic acid produced a significant elevation in liver enzymes that normalized with oxcarbazepine discontinuation and did not reappear with its reintroduction five days later. Conclusions Our findings suggest that a longer washout period or another agent should be considered when transitioning from valproic acid to oxcarbazepine.
科研通智能强力驱动
Strongly Powered by AbleSci AI